Cataract Prevention: The Evidence-Based Supplement Protocol

← Back to articles

Cataract is the leading cause of preventable blindness globally, and surgical removal is the definitive treatment. Supplements have a modest role in slowing progression before surgery becomes necessary, with the strongest evidence for nutrients involved in lens antioxidant defense. The two large nutrition-and-eye-disease trials — AREDS / AREDS2 (US) and the Linxian intervention trial (China) — provide most of the actionable evidence.

Lutein and Zeaxanthin, 10 + 2 mg Daily

Lutein and zeaxanthin are the carotenoids deposited in the lens (and macula) where they filter blue light and quench reactive oxygen species. AREDS2 showed that lutein 10 mg + zeaxanthin 2 mg daily was non-inferior to beta-carotene for AMD and was modestly associated with reduced rate of cataract surgery over 5 years. The signal is strongest in adults with low baseline carotenoid intake. See our lutein/zeaxanthin overview.

Vitamin C, 200–500 mg Daily

The lens contains the highest concentration of vitamin C of any tissue except adrenal cortex, where it serves as the primary aqueous antioxidant. Multiple observational studies have shown that adults with higher dietary vitamin C intake have lower rates of cataract formation. The Linxian trial in 23,000 Chinese adults showed that a vitamin C, B2, and trace-element supplement combination reduced nuclear cataract incidence over 5 years. AREDS isolated vitamin C in a higher-dose formulation that also reduced cataract progression in subgroup analysis. See our vitamin C dossier.

Vitamin E, 100–200 IU Daily

Vitamin E is the principal lipid-phase lens antioxidant. The AREDS formulation included 400 IU/day vitamin E and was associated with cataract progression delay. Outside AREDS, very-high-dose vitamin E (≥800 IU) has a small all-cause mortality signal in meta-analysis, so the recommended dose has come down to 100–200 IU mixed tocopherols daily.

Riboflavin (Vitamin B2), 1.5–3 mg Daily

Riboflavin is a cofactor for glutathione reductase, which regenerates reduced glutathione in the lens. The Linxian trial found that the riboflavin + niacin arm had significantly reduced nuclear cataract incidence over 5 years. Marginal riboflavin status is common in elderly adults — even RDA-equivalent supplementation moves the needle in deficient populations.

What NOT to Take

Avoid beta-carotene supplementation, particularly in smokers — the CARET and ATBC trials both showed increased lung cancer risk in smokers receiving beta-carotene. The AREDS2 reformulation specifically removed beta-carotene for this reason. Skip "eye health" megavitamin formulas that exceed AREDS doses by 5x — there is no incremental benefit and the cardiovascular and oncologic risks rise. Skip bilberry as a cataract intervention — observational data only. See our bilberry piece.

How to Run the Protocol

Schedule annual ophthalmologic exam from age 60. Smoking cessation is the single largest preventive intervention. Adopt a leafy-green-and-fish-rich diet (the AREDS food-pattern equivalent). Supplement lutein 10 mg + zeaxanthin 2 mg + vitamin C 200 mg + vitamin E 100 IU mixed tocopherols + riboflavin 5 mg daily. Surgical intervention when cataract impairs daily function. See the macular degeneration condition page for the parallel AMD context.